PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation. Tissue-selective energy delivery and short application times offer ...
"The risk/benefit ratio may be different in different populations with paroxysmal AF, such as those with serious heart disease, valvular heart disease, and heart failure. But risk of drug therapy is ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a navigation-enabled ablation catheter for the treatment of ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cryoablation (CRYO) is a novel catheter ablation technique for atrial fibrillation (AF). However, ...
Cryoablation (CRYO) is a novel catheter ablation technique for atrial fibrillation (AF). However, uncertainty persists regarding the role of metabolic modifications associated with CRYO. A study ...
The system enters a field that sees PFA catheters largely displacing thermal modalities for catheter ablation of AF.
Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late breaking research presented in a Hot ...
Pulmonary-vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation (PFA) is a nonthermal ablation method with few adverse effects beyond the myocardium. Data ...
Kardium Inc., an emerging leader in advanced solutions for atrial fibrillation, is proud to announce the publication of the ...
- FARAPULSE becomes first company in the world to commercialize a cardiac PFA system - MENLO PARK, Calif., Jan. 29, 2021 /CNW/ - FARAPULSE Inc. ("FARAPULSE" or "the Company") today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results